Parekh; Tejal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Parekh; Tejal.The latest application filed is for "novel peptides as ns3-serine protease inhibitors of hepatitis c virus".

Company Profile

0.8.11

Parekh; Tejal - Mountain View CA
Parekh; Tejal - Woodbridge NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant RE43,298 - Saksena , et al. April 3, 2	2012-04-03
Novel Peptides As Ns3-serine Protease Inhibitors Of Hepatitis C Virus App 20110117057 - Saksena; Anil K. ; et al.	2011-05-19
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,595,299 - Saksena , et al. September 29, 2	2009-09-29
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,244,721 - Saksena , et al. July 17, 2	2007-07-17
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20070032433 - Saksena; Anil K. ; et al.	2007-02-08
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,169,760 - Saksena , et al. January 30, 2	2007-01-30
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20060205672 - Saksena; Anil K. ; et al.	2006-09-14
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,012,066 - Saksena , et al. March 14, 2	2006-03-14
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050176648 - Saksena, Anil K. ; et al.	2005-08-11
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050059606 - Saksena, Anil K. ; et al.	2005-03-17
Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties Grant 6,846,802 - Chen , et al. January 25, 2	2005-01-25
Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus Grant 6,838,475 - Arasappan , et al. January 4, 2	2005-01-04
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20040254117 - Saksena, Anil K. ; et al.	2004-12-16
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 6,800,434 - Saksena , et al. October 5, 2	2004-10-05
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030216325 - Saksena, Anil K. ; et al.	2003-11-20
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030036501 - Saksena, Anil K. ; et al.	2003-02-20
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20020160962 - Saksena, Anil K. ; et al.	2002-10-31
Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties App 20020107181 - Chen, Kevin X. ; et al.	2002-08-08
Novel imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus App 20020102235 - Arasappan, Ashok ; et al.	2002-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.